Reversal of levofloxacin resistance in cystic fibrosis-associated Pseudomonas aeruginosa through dual inhibition of efflux pumps and DNA topoisomerases

C. M. Sloan; L. J. Sherrard; G. G. Einarsson; M. M. Tunney; D. G. Downey

doi:10.1016/S1569-1993(24)00234-0

Reversal of levofloxacin resistance in cystic fibrosis-associated Pseudomonas aeruginosa through dual inhibition of efflux pumps and DNA topoisomerases

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	EPS3.04
Pages (from-to)	S41
Number of pages	1
Journal	Journal of Cystic Fibrosis
Volume	23
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/S1569-1993(24)00234-0
Publication status	Published - 07 Jun 2024
Event	European Cystic Fibrosis Conference 2024 - Scottish Event Campus, Glasgow, United Kingdom Duration: 05 Jun 2024 → 08 Jun 2024 https://www.ecfs.eu/glasgow2024

Access to Document

10.1016/S1569-1993(24)00234-0Licence: Unspecified

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance
Sloan, C. M. (Author), Downey, D. (Supervisor) & Sherrard, L. (Supervisor), Dec 2024
Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

@article{1d54ebd9180c4969925d169475c1dc14,

title = "Reversal of levofloxacin resistance in cystic fibrosis-associated Pseudomonas aeruginosa through dual inhibition of efflux pumps and DNA topoisomerases",

author = "Sloan, \{C. M.\} and Sherrard, \{L. J.\} and Einarsson, \{G. G.\} and Tunney, \{M. M.\} and Downey, \{D. G.\}",

year = "2024",

month = jun,

day = "7",

doi = "10.1016/S1569-1993(24)00234-0",

language = "English",

volume = "23",

pages = "S41",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

number = "Supplement 1",

note = "European Cystic Fibrosis Conference 2024, ECFS2024 ; Conference date: 05-06-2024 Through 08-06-2024",

url = "https://www.ecfs.eu/glasgow2024",

}

Reversal of levofloxacin resistance in cystic fibrosis-associated Pseudomonas aeruginosa through dual inhibition of efflux pumps and DNA topoisomerases. / Sloan, C. M.; Sherrard, L. J.; Einarsson, G. G. et al.
In: Journal of Cystic Fibrosis, Vol. 23, No. Supplement 1, EPS3.04, 07.06.2024, p. S41.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Reversal of levofloxacin resistance in cystic fibrosis-associated Pseudomonas aeruginosa through dual inhibition of efflux pumps and DNA topoisomerases

AU - Sloan, C. M.

AU - Sherrard, L. J.

AU - Einarsson, G. G.

AU - Tunney, M. M.

AU - Downey, D. G.

PY - 2024/6/7

Y1 - 2024/6/7

U2 - 10.1016/S1569-1993(24)00234-0

DO - 10.1016/S1569-1993(24)00234-0

M3 - Meeting abstract

SN - 1569-1993

VL - 23

SP - S41

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - Supplement 1

M1 - EPS3.04

T2 - European Cystic Fibrosis Conference 2024

Y2 - 5 June 2024 through 8 June 2024

ER -

Reversal of levofloxacin resistance in cystic fibrosis-associated Pseudomonas aeruginosa through dual inhibition of efflux pumps and DNA topoisomerases

Access to Document

Student theses

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance

Cite this